Insider · CIK 0001734779

Cross Shawn

Reports to the SEC for 5 companies · BRISBANE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001734779

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-04-23	PCRXPacira BioSciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−12.9K sh	—	—	150,000
2026-04-23	PCRXPacira BioSciences, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+12.9K sh	$16.45	+$213K	118,282
2026-04-23	PCRXPacira BioSciences, Inc.S Sale	Chief Financial Officer	SSale	−12.9K sh	$25.16	−$326K	105,341
2026-04-22	PCRXPacira BioSciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−1,500 sh	—	—	162,941
2026-04-22	PCRXPacira BioSciences, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+1,500 sh	$16.45	+$24.7K	106,841
2026-04-22	PCRXPacira BioSciences, Inc.S Sale	Chief Financial Officer	SSale	−1,500 sh	$25.01	−$37.5K	105,341
2026-04-21	PCRXPacira BioSciences, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+2,845 sh	$16.45	+$46.8K	108,186
2026-04-21	PCRXPacira BioSciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−2,845 sh	—	—	164,441
2026-04-21	PCRXPacira BioSciences, Inc.S Sale	Chief Financial Officer	SSale	−2,845 sh	$25.01	−$71.2K	105,341
2026-04-20	PCRXPacira BioSciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−7,714 sh	—	—	167,286
2026-04-20	PCRXPacira BioSciences, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+7,714 sh	$16.45	+$127K	113,055
2026-04-20	PCRXPacira BioSciences, Inc.S Sale	Chief Financial Officer	SSale	−7,714 sh	$25.14	−$194K	105,341
2026-02-11	PCRXPacira BioSciences, Inc.A Award	Chief Financial Officer	AAward	+49.1K sh	—	—	105,341
2025-12-10	PCRXPacira BioSciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−9,104 sh	—	—	175,000
2025-12-10	PCRXPacira BioSciences, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+9,104 sh	$16.45	+$150K	65,354
2025-12-10	PCRXPacira BioSciences, Inc.S Sale	Chief Financial Officer	SSale	−9,104 sh	$25.14	−$229K	56,250
2025-12-09	PCRXPacira BioSciences, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+15.9K sh	$16.45	+$261K	72,146
2025-12-09	PCRXPacira BioSciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−15.9K sh	—	—	184,104
2025-12-09	PCRXPacira BioSciences, Inc.S Sale	Chief Financial Officer	SSale	−15.9K sh	$25.03	−$398K	56,250
2025-11-10	PCRXPacira BioSciences, Inc.S Sale	Chief Financial Officer	SSale	−12.1K sh	$22.09	−$266K	56,250
2025-10-31	PCRXPacira BioSciences, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−6,690 sh	$21.38	−$143K	68,310
2025-02-27	Cyclo Therapeutics, Inc.A Award	Director	AAward	+28.6K sh	—	—	136,346
2024-11-15	Cyclo Therapeutics, Inc.A Award	Director	AAward	+17.2K sh	—	—	107,749
2024-11-04	PCRXPacira BioSciences, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+200K sh	—	—	200,000
2024-11-01	PCRXPacira BioSciences, Inc.A Award	Chief Financial Officer	AAward	+75K sh	—	—	75,000
2024-08-16	Cyclo Therapeutics, Inc.A Award	Director	AAward	+9,028 sh	—	—	90,521
2024-06-03	Cyclo Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+15.6K sh	—	—	15,562
2024-06-03	Cyclo Therapeutics, Inc.A Award	Director	AAward	+8,887 sh	—	—	81,493
2023-12-27	Applied Molecular Transport Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CEO & Chair of the Board	DDisposition to Issuer	−300K sh	—	—	0
2023-12-27	Applied Molecular Transport Inc.D Disposition to Issuer	Director, CEO & Chair of the Board	DDisposition to Issuer	−545K sh	—	—	0
2023-12-27	Applied Molecular Transport Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CEO & Chair of the Board	DDisposition to Issuer	−63K sh	—	—	0
2023-12-27	Applied Molecular Transport Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CEO & Chair of the Board	DDisposition to Issuer	−94.5K sh	—	—	0
2023-12-27	Applied Molecular Transport Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CEO & Chair of the Board	DDisposition to Issuer	−84K sh	—	—	0
2023-12-27	Applied Molecular Transport Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CEO & Chair of the Board	DDisposition to Issuer	−668K sh	—	—	0
2023-12-27	Cyclo Therapeutics, Inc.A Award	Director	AAward	+72.6K sh	—	—	72,606
2023-12-27	Cyclo Therapeutics, Inc.Stock Option (Right to buy)A Award	Director	AAward	+88.9K sh	—	—	89,910
2023-11-22	Applied Molecular Transport Inc.S Sale	Director, CEO & Chair of the Board	SSale	−111K sh	$0.16	−$18.1K	545,499
2023-11-15	Applied Molecular Transport Inc.S Sale	Director, CEO & Chair of the Board	SSale	−90.4K sh	$0.16	−$14.5K	656,301
2023-09-29	Applied Molecular Transport Inc.S Sale	Director, CEO & Chair of the Board	SSale	−194K sh	$0.16	−$30.7K	752,307
2023-09-28	Applied Molecular Transport Inc.A Award	Director, CEO & Chair of the Board	AAward	+886K sh	—	—	946,267
2023-09-05	Applied Molecular Transport Inc.S Sale	Director, CEO & Chair of the Board	SSale	−1,253 sh	$0.21	−$259.998	746,748
2023-06-02	Applied Molecular Transport Inc.S Sale	Director, CEO & Chair of the Board	SSale	−477 sh	$0.24	−$114.575	748,001
2023-06-02	Applied Molecular Transport Inc.S Sale	Director, CEO & Chair of the Board	SSale	−3,293 sh	$0.24	−$794.272	749,014
2023-06-02	Applied Molecular Transport Inc.S Sale	Director, CEO & Chair of the Board	SSale	−536 sh	$0.24	−$128.854	748,478
2023-03-24	Applied Molecular Transport Inc.Stock Option (Right to Buy)A Award	Director, CEO & Chair of the Board	AAward	+668K sh	—	—	668,000
2023-03-01	Applied Molecular Transport Inc.S Sale	Director, CEO & Chair of the Board	SSale	−934 sh	$0.50	−$467	60,156
2022-12-02	Applied Molecular Transport Inc.S Sale	Director, CEO & Chair of the Board	SSale	−3,893 sh	$1.05	−$4,088.039	61,090
2022-09-01	Applied Molecular Transport Inc.S Sale	Director, CEO & Chair of the Board	SSale	−468 sh	$1.42	−$664.7	65,399
2022-09-01	Applied Molecular Transport Inc.S Sale	Director, CEO & Chair of the Board	SSale	−416 sh	$1.42	−$590.678	64,983
2022-06-02	Applied Molecular Transport Inc.S Sale	Director, CEO & Chair of the Board	SSale	−2,166 sh	$3.04	−$6,590.055	65,867

Recent filings

Accepted (ET)
Apr 244
Cross Shawn0001628280-26-027287
SEC(opens sec.gov)
Apr 224
Cross Shawn0001628280-26-026669
SEC(opens sec.gov)
Feb 134
Cross Shawn0001628280-26-008080
SEC(opens sec.gov)
Dec 114
Cross Shawn0001628280-25-056645
SEC(opens sec.gov)
Nov 134
Cross Shawn0001628280-25-052038
SEC(opens sec.gov)

Companies

Address

C/O PACIRA BIOSCIENCES, INC. 2000 SIERRA POINT PARKWAY, SUITE 900

BRISBANE, CA, 94005